SCID-AI · 405 SNS Axis Business Space, Nanpura, Surat
Mon–Sat: 11–1 PM & 4–6 PM
 Disease Guide · Medically Reviewed

Chikungunya Fever, Joint Pain & Post-Chikungunya Arthritis

Reviewed by Dr. Pratik Savaj, FNB Infectious Diseases, SCID-AI, Surat
Updated: May 2026 · 9 sections

Chikungunya is a viral infection spread by the Aedes mosquito. The fever resolves in days — but the joint pain can be debilitating for months. Understanding chikungunya means understanding that the fever is the beginning of the illness, not the whole illness. Post-chikungunya arthritis (PCA) affects 30–40% of patients and requires specialist management.

2–4dFever duration
30–40%Develop post-CHIK arthritis
MonthsJoint pain can persist
AedesSame mosquito as dengue
Chikungunya fever and joint pain — SCID-AI Surat

 Same mosquito as dengue

Vector:Aedes aegypti & albopictus
Bites:Daytime — morning & late afternoon
Differs:Joint pain is the dominant feature
Understanding Chikungunya

What Is Chikungunya?

Chikungunya is caused by the chikungunya virus (CHIKV) — an alphavirus in the family Togaviridae. It was first identified during an outbreak in Tanzania in 1952. The name “chikungunya” comes from the Makonde language and means “that which bends up” — describing the stooped posture of patients suffering from severe joint pain.

CHIKV is transmitted to humans exclusively by the bite of an infected Aedes aegypti or Aedes albopictus mosquito — the same vectors as dengue fever. This means chikungunya and dengue often co-circulate in the same outbreaks, in the same geographic areas, at the same time. In Surat during monsoon, both viruses are frequently active simultaneously.

What makes chikungunya clinically unique is the severity and persistence of joint pain. While the fever typically resolves within 2–4 days, the arthritis — inflammation of multiple joints — can persist for months to years in a significant proportion of patients, significantly impairing quality of life. This post-chikungunya arthritis (PCA) is not simply residual soreness — it is active, immune-mediated joint inflammation requiring specific specialist management.

Why the Name Means “That Which Bends Up”

The classic clinical picture of chikungunya — patients walking hunched over due to bilateral ankle, knee, wrist, and finger joint pain — is so characteristic that it gave the disease its name. This bilateral, symmetrical, migratory polyarthritis affecting small and large joints simultaneously is the clinical signature that distinguishes chikungunya from dengue (where joint pain is present but less dominant) and from malaria (where joint pain is mild).

Dr. Pratik Savaj

Dr. Pratik Savaj

FNB Infectious Diseases · SCID-AI, Surat
Chikungunya & post-CHIK arthritis specialist

Chikungunya joint pain — bilateral polyarthritis
Disease Course

The 4 Phases of Chikungunya — From Fever to Recovery

Chikungunya has a distinct progression across four phases. Understanding these phases is essential — most patients expect recovery when the fever resolves, but the joint phase is just beginning at that point.

Days 1–4

Acute Febrile Phase

High fever, joint pain onset, rash

 High fever 39–40°C, sudden onset
 Severe joint pain begins within 24 hrs
 Maculopapular rash on trunk and limbs
 Headache, fatigue, muscle aches
Exclude dengue simultaneously — NS1 + dengue IgM
Days 5–14

Sub-Acute Joint Phase

Fever resolves, joint pain peaks

 Fever resolves — but joint pain intensifies
 Bilateral, symmetrical joint swelling
 Morning stiffness — joints worst after rest
 NSAIDs now safe (dengue excluded)
Most patients assume they’re recovering — this phase surprises many
Weeks to Years

Post-Chikungunya Arthritis

30–40% of patients. Months of pain.

 Affects 30–40% of chikungunya patients
 Persistent joint inflammation resembling RA
 Hydroxychloroquine + physiotherapy
 Specialist management improves outcomes
Elderly patients most severely affected
Months to Years

Full Recovery

Most patients recover completely

 Majority recover fully within 3–6 months
 Lifelong immunity to chikungunya
 10–15% have chronic arthritis beyond 1 year
 Early specialist management reduces chronicity
Differential Diagnosis

Chikungunya vs Dengue — Same Mosquito, Different Danger

Both are transmitted by the Aedes mosquito and co-circulate in Surat during monsoon. Both start with sudden high fever and body pain. But their clinical course, primary danger, and management are completely different — accurate diagnosis is essential.

Chikungunya Primary danger: prolonged, disabling joint pain
Fever
High fever, 2–4 days then resolves
Joint pain
Severe, bilateral, symmetrical polyarthritis — the dominant feature. Small and large joints. Migratory.
Rash
Maculopapular rash on trunk and extremities, common
Platelets
Usually normal or mildly low — not a primary concern
Main danger
Post-chikungunya arthritis lasting months to years (30–40%)
Diagnostic test
Chikungunya IgM (from day 5) or RT-PCR (days 1–7)
NSAIDs safe?
Yes — after dengue excluded. NSAIDs are the main treatment for joint pain
Long-term risk
Chronic arthritis — specialist management needed
VS
Dengue Primary danger: platelet drop, haemorrhage, shock
Fever
High fever, 5–7 days — longer than chikungunya
Joint pain
Moderate body and joint aches (“break-bone fever”) — less severe and not persistent after fever
Rash
Characteristic “islands of white in sea of red” — days 2–5
Platelets
Significant platelet drop — daily monitoring essential
Main danger
Severe dengue: haemorrhage, plasma leakage, shock (life-threatening)
Diagnostic test
NS1 antigen (days 1–5), IgM (from day 5)
NSAIDs safe?
Never — increases bleeding risk in dengue. Paracetamol only.
Long-term risk
Fully resolves after recovery — no persistent joint disease

Always Test for Both in Surat During Monsoon

Chikungunya and dengue co-infection is possible — and both viruses circulate simultaneously in Surat during monsoon. Always order dengue NS1 + chikungunya IgM together when either is suspected. A positive chikungunya result does not exclude dengue, and vice versa. NSAID use for chikungunya joint pain is only safe after dengue has been formally excluded by negative NS1 and negative dengue IgM after day 5.

Chikungunya Joint Pain

Which Joints Are Affected — and Why It Hurts So Much

The joint pain in chikungunya is not a non-specific viral ache. It is true arthritis — synovial inflammation within the joint space caused by direct viral invasion of the joint tissue. CHIKV infects synovial fibroblasts and macrophages within joints, triggering an intense local inflammatory response that can continue even after the virus has been cleared.

The arthritis is characteristically bilateral, symmetrical, and polyarticular — affecting multiple joints on both sides of the body simultaneously. It has a migratory quality — the pain may be more intense in one joint on one day and shift to another joint the next day, while always maintaining its bilateral symmetrical pattern.

Most Commonly Affected Joints

Ankles and feet — the most commonly and severely affected joints. The stooped gait and inability to walk normally is usually due to ankle involvement.
Wrists — second most commonly affected. Wrist pain and stiffness makes everyday tasks like gripping objects, writing, and cooking extremely painful.
Finger and toe joints — small joint involvement is characteristic. Morning stiffness in fingers — similar to rheumatoid arthritis — is a common complaint.
Knees and elbows — large joints are also commonly involved, often with periarticular swelling and pitting oedema around the joint.
Shoulders — shoulder pain and restricted movement, particularly with elevation and rotation, is present in severe cases.

Morning Stiffness — The Hallmark of Post-Chikungunya Arthritis

Morning stiffness — joints being worst after a period of rest and gradually improving with movement — is the hallmark of inflammatory arthritis, not just viral muscle aching. In post-chikungunya arthritis, morning stiffness lasting more than 30 minutes is a diagnostic indicator of ongoing synovial inflammation requiring specific treatment, not just paracetamol and waiting.

Joints Commonly Affected by Chikungunya

Ankles & feet
Most severely affected — walking impaired
Wrists
Grip and daily tasks affected
Finger joints
Morning stiffness — RA-like
Toe joints
Walking and footwear affected
Knees
Swelling and restricted movement
Elbows
Extension restricted
Shoulders
Elevation and rotation limited
Spine (rare)
Back and neck pain in severe cases

Key Pattern

Bilateral + Symmetrical + Migratory — both ankles, both wrists, both finger joints. Pain may shift emphasis from one joint to another but remains symmetrical. This pattern distinguishes CHIK arthritis from a traumatic or septic joint injury.

Post-Chikungunya Arthritis

PCA — When Joint Pain Persists After the Fever

Post-chikungunya arthritis (PCA) is defined as arthritis persisting or recurring after the acute chikungunya fever has fully resolved — typically beyond 3 months from the original infection. It affects approximately 30–40% of adults infected with chikungunya, with higher rates in elderly patients (up to 65%).

PCA is not simply tiredness or delayed recovery. It is active, immune-mediated synovial inflammation — the same basic mechanism as rheumatoid arthritis — triggered by the original CHIKV infection and perpetuated by the immune system even after the virus has been cleared. In some patients, the joint inflammation becomes self-sustaining and can cause permanent joint damage if not treated.

Post-chikungunya arthritis specialist consultation
 Sub-acute PCA (Weeks 3–12)
 Persistent bilateral joint pain after fever resolution — continuing or worsening despite paracetamol
 Morning stiffness lasting 30 minutes or more — joints worse after rest, gradually improving with gentle movement
 Periarticular swelling (puffiness around joints) and tenderness to touch
 Treatment: NSAIDs (ibuprofen, naproxen) + hydroxychloroquine 200–400 mg/day
 Physiotherapy — gentle range-of-motion exercises improve joint function
 Chronic PCA (Beyond 3 Months)
 Affects 10–15% of chikungunya patients — arthritis persistent beyond 12 months. More common in elderly and those with pre-existing joint disease.
 Rheumatoid-like pattern — symmetrical polyarthritis with erosive changes visible on X-ray in severe long-standing cases
 Requires rheumatological assessment — ANA, RF, anti-CCP to distinguish from de novo autoimmune arthritis triggered by chikungunya
 Treatment: Hydroxychloroquine ± Methotrexate ± short courses of low-dose steroids. No DMARDs for short-term PCA.
 Do not use long-term systemic steroids — risk of rebound arthritis and steroid complications without definitive benefit

Why Elderly Patients Need Early Specialist Involvement

In patients over 60, chikungunya arthritis is more severe, lasts longer, and is more likely to become chronic. Pre-existing osteoarthritis in elderly joints creates a more vulnerable joint environment. Elderly patients with chikungunya arthritis should see Dr. Savaj within 2 weeks of diagnosis — early hydroxychloroquine therapy significantly reduces the risk of progression to chronic PCA.

Chikungunya Diagnosis

How Chikungunya Is Diagnosed

1

Chikungunya RT-PCR (Days 1–7)

Acute phase · Most sensitive

Chikungunya RT-PCR detects CHIKV viral RNA in blood during active viraemia. It is highly sensitive and specific during the first 7 days of illness — positive from day 1. It is the most accurate test for acute chikungunya but is more expensive and less widely available than IgM serology. Used in clinically uncertain cases or for outbreak surveillance. A positive PCR definitively confirms active chikungunya infection.

2

Chikungunya IgM Antibody (From Day 5)

Most used test in Surat

Chikungunya-specific IgM antibodies appear in blood from approximately day 4–5 of illness and remain positive for several months. This is the most commonly used chikungunya diagnostic test in Surat due to its availability and lower cost. A positive chikungunya IgM confirms recent infection. IgM may occasionally cross-react with other alphaviruses. In clinical practice, a positive IgM in the context of typical bilateral polyarthritis and a compatible epidemiological setting (Surat, monsoon) is highly reliable.

3

Dengue Co-Testing (Always)

Mandatory in Surat

Because chikungunya and dengue co-circulate in Surat and both are spread by the same Aedes mosquito, always test for dengue simultaneously: NS1 antigen (days 1–5) and dengue IgM (from day 5). This is not optional — it is clinically necessary because: (1) Co-infection is possible; (2) NSAID use for chikungunya joint pain is only safe after dengue is formally excluded; (3) Missing dengue in a patient with concurrent chikungunya has potentially life-threatening consequences.

4

Blood Count and Inflammatory Markers

Severity and monitoring

Complete blood count (CBC) — platelet count is important to confirm that it is not falling significantly (which would suggest concurrent dengue). Chikungunya typically causes only a mild decrease in platelet count. ESR and CRP — acute phase reactants that are elevated in active chikungunya arthritis and help monitor response to treatment in post-chikungunya arthritis. In chronic PCA, rheumatological markers (RF, ANA, anti-CCP) are sent to distinguish PCA from de novo autoimmune arthritis.

5

Joint X-Ray (Chronic PCA Only)

If arthritis persists beyond 3 months

In patients with chronic PCA lasting more than 3 months, X-rays of the most affected joints are ordered to look for erosive changes — joint space narrowing and marginal erosions that indicate progressive arthritis. MRI of severely affected joints (particularly wrists and ankles) provides more sensitive early detection of synovitis and erosive disease. These findings guide decisions about escalating from hydroxychloroquine to methotrexate or other DMARDs.

Chikungunya IgM laboratory diagnosis

 Which Test to Order When

Days 1–5: Chikungunya RT-PCR + Dengue NS1 + CBC
From day 5: Chikungunya IgM + Dengue IgM + NS1 + CBC
After 3 weeks: ESR, CRP, RF, ANA if arthritis persisting
After 3 months: X-ray joints + anti-CCP + consider specialist referral

NSAID Timing Rule

Use only paracetamol until dengue is excluded. Once dengue NS1 is negative and dengue IgM is negative (after day 5), NSAIDs (ibuprofen, naproxen) are safe and are the correct treatment for chikungunya joint pain.

 Book Chikungunya Assessment
Chikungunya Treatment

How Chikungunya Is Treated — Phase by Phase

There is no specific antiviral treatment for chikungunya. Treatment is based on the phase of illness and targets the dominant problem — fever and initial symptoms in the acute phase, and joint inflammation in the sub-acute and chronic phases.

Acute Phase (Days 1–4)

Fever management

 Paracetamol only for fever — until dengue is formally excluded. 500–1000 mg every 6–8 hours.
 Adequate hydration — 3–4 litres/day. Viral illness increases fluid requirements.
 Rest — minimise weight-bearing activity while joints are most acutely inflamed.
 No aspirin, no ibuprofen until dengue is excluded. Increases bleeding risk in dengue.
 Test for dengue (NS1 + CBC) on day 1 to allow early NSAID use once excluded.

Joint Phase & PCA (Weeks 2+)

Anti-inflammatory specialist management

 NSAIDs — Ibuprofen 400–800 mg TID or Naproxen 500 mg BD. First-choice for joint pain once dengue excluded. Take with food.
 Hydroxychloroquine 200–400 mg/day — cornerstone of PCA management. Takes 4–6 weeks for onset of action. Requires baseline eye exam.
 Physiotherapy — gentle range-of-motion exercises twice daily. Warm water exercises (hydrotherapy) particularly effective for lower limb joints.
 Intra-articular steroid injections — for single severely affected joints not responding to systemic NSAIDs. Short-duration relief.
 Avoid long-term oral steroids — rebound arthritis on withdrawal; significant systemic side effects without definitive benefit in PCA.

Chronic PCA (Beyond 3 Months)

Disease-modifying therapy

 Continue hydroxychloroquine — typically for 12–18 months in chronic PCA. Annual eye review mandatory.
 Methotrexate — added in erosive disease or inadequate response to hydroxychloroquine alone. 10–20 mg weekly with folate supplementation.
 Rheumatological review — to distinguish PCA from de novo rheumatoid arthritis (which occasionally presents after chikungunya).
 Physiotherapy program — supervised, progressive exercise to maintain joint function and prevent deconditioning.
 Most patients recover fully — realistic prognosis counselling reduces anxiety and improves treatment adherence.
Chikungunya Prevention

Preventing Chikungunya — Mosquito Control and Protection

Chikungunya prevention is mosquito prevention — specifically preventing bites from the day-biting Aedes mosquito. The same measures prevent dengue, making Aedes mosquito control a high-value public health investment.

Eliminate Aedes Breeding Sites Weekly

Aedes mosquitoes breed in small amounts of clean, stagnant water. Empty, clean, or cover all containers weekly — coolers, flower pots, tyres, buckets, bird baths, and roof gutters. Even a discarded bottle cap holding water is sufficient for Aedes breeding. This is the single most effective prevention measure and must be done on a weekly basis, not monthly.

Day-Time Protection — DEET and Clothing

Aedes bites primarily during the day — morning and late afternoon. Unlike malaria (night-biting Anopheles), bed nets have limited value against Aedes. Use DEET-based repellents (at least 20% DEET) on exposed skin. Wear long-sleeved clothing and long trousers during peak biting hours, particularly outdoors during monsoon.

Mosquito Screens on Windows and Doors

Fine-mesh wire screens on windows and doors prevent Aedes entry into the home during the day — when mosquitoes are actively biting. Use window screens and keep doors closed during peak biting hours. Insecticide-treated curtains provide additional protection and reduce mosquito density indoors.

Protect Chikungunya Patients from Mosquito Bites

A chikungunya patient is viremic (virus in blood) for approximately 5–7 days after symptom onset. If an Aedes mosquito bites an infected patient during this window, it can transmit chikungunya to the next person it bites. Patients should stay indoors where possible, use repellents, and sleep under fine-mesh nets to prevent transmission to household members.

Vaccine (Consult Specialist for Availability)

IXCHIQ (VLA1553) — a live-attenuated chikungunya vaccine — was approved by the US FDA and EMA in 2023–2024. It provides strong protection in adults 18+ as a single dose. Availability in India is currently limited but may be accessible through travel medicine clinics for travellers to endemic areas. Dr. Savaj can advise on current availability at SCID-AI.

Chikungunya prevention — mosquito control Surat
Frequently Asked Questions

Common Questions About Chikungunya

Questions patients ask about chikungunya — answered by Dr. Pratik Savaj, FNB Infectious Diseases, SCID-AI, Surat.

How long does chikungunya joint pain last?
The acute joint pain during the fever phase (first 1–2 weeks) is severe but temporary. However, post-chikungunya arthritis (PCA) — persistent joint pain after the fever has fully resolved — affects 30–40% of patients and can last months to years. Most patients recover within 3–6 months. However, 10–15% develop chronic arthritis lasting more than a year — particularly elderly patients and those with pre-existing joint disease. Early specialist management of PCA significantly improves outcomes.
Is chikungunya the same as dengue?
No — they are completely different viral infections. Both are spread by the Aedes aegypti and Aedes albopictus mosquitoes, which is why they frequently co-circulate in the same outbreak. Key differences: Dengue causes a significant platelet drop (thrombocytopenia) — the primary danger; joint pain is moderate. Chikungunya causes extremely severe, disabling joint pain — the defining feature; platelet count is usually normal or mildly affected. The risk in Surat during outbreaks is that both are circulating simultaneously and initial presentation is similar.
Why does chikungunya cause such severe joint pain?
Chikungunya virus (CHIKV) has a specific tropism for joint tissue — it directly infects synovial fibroblasts and macrophages within joint spaces, triggering intense local inflammation. This direct viral infection of joint tissue explains why the pain is so much more severe than in dengue, and why it persists even after the virus is cleared — the joint inflammation (synovitis) continues as the immune system responds to viral antigens in the joint tissue. In post-chikungunya arthritis, the joint inflammation becomes self-sustaining, resembling rheumatoid arthritis.
Can I take ibuprofen for chikungunya joint pain?
This depends on the phase of illness and whether dengue has been excluded. During the first 5 days of fever, when dengue cannot yet be excluded clinically, use only paracetamol — ibuprofen increases bleeding risk if the fever is actually dengue. After dengue is confirmed negative (negative NS1 and dengue IgM after day 5) and chikungunya is diagnosed, NSAIDs (ibuprofen, naproxen, diclofenac) can be used for joint pain. For post-chikungunya arthritis lasting months, hydroxychloroquine and supervised physiotherapy are the cornerstone of management.
Can chikungunya come back or relapse?
Chikungunya itself does not relapse — once you have been infected, you develop lifelong immunity to the same CHIKV strain. However, post-chikungunya arthritis (PCA) can persist or flare for months to years after the acute infection. This is not a relapse of the virus — the virus is gone. It is an ongoing immune-mediated joint inflammation triggered by the original infection. Some patients develop a pattern of joint pain that waxes and wanes for years, requiring long-term specialist management.
Is there a vaccine for chikungunya?
A chikungunya vaccine — IXCHIQ (Valneva VLA1553) — was approved by the US FDA in 2023 and EMA in 2024. It is a live-attenuated vaccine given as a single dose, providing strong protection against chikungunya in adults 18 years and older. As of mid-2026, it is not yet widely available in India but may be available for travellers through travel medicine clinics. Dr. Savaj can advise on current availability and alternatives at SCID-AI. Mosquito control and personal protection remain the primary prevention strategy in India.
How is chikungunya diagnosed?
Chikungunya diagnosis depends on the timing of testing. During the first 5 days (acute phase): Chikungunya RT-PCR detects viral RNA in blood — highly sensitive and specific. From day 5 onwards: Chikungunya IgM antibody test — detects the immune response. IgM remains positive for several months after acute infection. IgG antibody: Indicates past infection, persists lifelong. In clinical practice, chikungunya IgM is the most commonly used diagnostic test in Surat given availability and cost. Always test for dengue simultaneously, as co-infection is possible and both circulate in Surat.
Why are the elderly affected worse by chikungunya?
Elderly patients have significantly worse outcomes with chikungunya for several reasons: (1) Pre-existing joint disease — osteoarthritis in elderly joints creates a more vulnerable joint environment for viral inflammation to become established and persistent. (2) Reduced immune clearance — the ageing immune system is less effective at clearing CHIKV from joint tissue, allowing longer viral persistence and more prolonged inflammation. (3) Reduced tolerance for NSAIDs — elderly patients have higher GI and renal risks from anti-inflammatory drugs, limiting pain management options. Early specialist involvement is especially important for elderly chikungunya patients.
Consult Dr. Pratik Savaj

Joint Pain After Chikungunya? Get Specialist Care.

No referral needed. Post-chikungunya arthritis requires specialist management — not just paracetamol and waiting. Early hydroxychloroquine therapy significantly reduces the risk of chronic arthritis. Dr. Pratik Savaj, FNB Infectious Diseases, SCID-AI, Nanpura, Surat.

SCID-AI, Nanpura, Surat — 405 SNS Axis Business Space, Besides Mahavir Hospital, Surat 395001
Mon–Sat: 11 AM–1 PM & 4–6 PM · Sunday: Closed
+91 72839 34807 — Call or WhatsApp
Chikungunya consultation — SCID-AI, Nanpura, Surat